secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2021-08-04T23:59:59+00:00
Accession:  0001157523-21-000990
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q2 revenue $914.6M (+34% YoY); raises 2021 guidance above prior estimates
--------------------------------------------------------------------------------

- Revenue $914.6M, +34% YoY (organic +24.1%); GAAP EPS $1.72, non-GAAP EPS $2.61.
- Non-GAAP EPS of $2.61 beat prior year $1.58; net income $88.4M GAAP, $133.8M non-GAAP.
- All three segments drove organic growth: RMS +44.5%, DSA +18.1%, Manufacturing +26.6%.
- 2021 guidance raised: revenue growth 20.5-22.5% (was 19-21%), non-GAAP EPS $10.10-$10.35 (was $9.75-$10.00), FCF ~$500M.
- CEO cites robust client demand and strengthened portfolio; company adding staff and capacity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752321000990/0001157523-21-000990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752321000990/a52470970.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-000990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer